Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef T Prchal

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
American Journal of Hematology|January 23, 2026
Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline MutationLucie Lanikova, Dusan Hrckulak, Veronika Zimolova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
New syndrome of paraganglioma and somatostatinoma associated with polycythemiaKarel Pacak, Ivana Jochmanova, Tamara Prodanov, et al.
The Journal of Biological Chemistry|June 22, 2006
Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse developmentDonghoon Yoon, Yves D Pastore, Vladimir Divoky, et al.
Haematologica|May 25, 2011
The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemiaGalina Y Miasnikova, Adelina I Sergueeva, Mehdi Nouraie, et al.
Leukemia|March 21, 2018
Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responsesTsewang Tashi, Sabina Swierczek, Soo Jin Kim, et al.
Blood|July 23, 2005
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemiaJaroslav Jelinek, Yasuhiro Oki, Vazganush Gharibyan, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Endemic polycythemia in Russia: mutation in the VHL geneSonny O Ang, Hua Chen, Victor R Gordeuk, et al.
Stem Cells (Dayton, Ohio)|October 10, 2013
Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cellsZhaohui Ye, Cyndi F Liu, Lucie Lanikova, et al.
American Journal of Hematology|June 23, 2023
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosisJihyun Song, Krishna M Sundar, Monika Horvathova, et al.
Blood Advances|March 5, 2026
Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 studyHaris Ali, Sanjay Ram Mohan, Ashwin Kishtagari, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
American Journal of Hematology|January 23, 2026
Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline MutationLucie Lanikova, Dusan Hrckulak, Veronika Zimolova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
New syndrome of paraganglioma and somatostatinoma associated with polycythemiaKarel Pacak, Ivana Jochmanova, Tamara Prodanov, et al.
The Journal of Biological Chemistry|June 22, 2006
Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse developmentDonghoon Yoon, Yves D Pastore, Vladimir Divoky, et al.
Haematologica|May 25, 2011
The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemiaGalina Y Miasnikova, Adelina I Sergueeva, Mehdi Nouraie, et al.
Leukemia|March 21, 2018
Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responsesTsewang Tashi, Sabina Swierczek, Soo Jin Kim, et al.
Blood|July 23, 2005
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemiaJaroslav Jelinek, Yasuhiro Oki, Vazganush Gharibyan, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Endemic polycythemia in Russia: mutation in the VHL geneSonny O Ang, Hua Chen, Victor R Gordeuk, et al.
Stem Cells (Dayton, Ohio)|October 10, 2013
Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cellsZhaohui Ye, Cyndi F Liu, Lucie Lanikova, et al.
American Journal of Hematology|June 23, 2023
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosisJihyun Song, Krishna M Sundar, Monika Horvathova, et al.
Blood Advances|March 5, 2026
Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 studyHaris Ali, Sanjay Ram Mohan, Ashwin Kishtagari, et al.
Pageof 25